HBV
HBV inhibitors are compounds designed to target and inhibit various stages of the Hepatitis B virus (HBV) lifecycle. These inhibitors can interfere with viral replication, assembly, or release, thereby reducing the viral load and helping to manage chronic HBV infections. Research into HBV inhibitors is crucial for developing effective antiviral therapies to prevent liver disease and cancer associated with HBV. At CymitQuimica, we offer a range of HBV inhibitors to support your research in virology, antiviral drug development, and infectious disease management.
Found 188 products of "HBV"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Helioxanthin 8-1
CAS:Helioxanthin 8-1, an analogue of helioxanthin, exhibits significant in vitro anti-HBV/HCV/HSV-1/HIV activity with EC50 of >5/10/1.4/15 μM.Formula:C20H12N2O6Purity:98%Color and Shape:SolidMolecular weight:376.32BA38017
CAS:BA38017 is a potent assembly modulator of HBV core protein that inhibits the replication of HBV (EC50 = 0.20 μM) [1].Formula:C15H11ClFNO3Color and Shape:SolidMolecular weight:307.7Clevudine triphosphate
CAS:Clevudine triphosphate is a TTP analog that is able to inhibit protein priming independently of the deoxynucleoside triphosphate substrate.Formula:C10H16FN2O14P3Purity:98%Color and Shape:SolidMolecular weight:500.16HBV-IN-9
CAS:HBV-IN-9 inhibits HBsAg (IC50: 10 nM) and HBV DNA replication (IC50: 0.15 nM) per WO2018001952A1.Formula:C22H24FN7OColor and Shape:SolidMolecular weight:421.47HBV-IN-7
CAS:HBV-IN-6 is a potent inhibitor of HBV (EC50: 5 nM).Formula:C18H17ClFN3O5S2Color and Shape:SolidMolecular weight:473.93trans-ccc_R08
CAS:trans-ccc_R08: potent cccDNA inhibitor, IC50 0.08 µM, may help research HBV.Formula:C22H19ClO6Color and Shape:SolidMolecular weight:414.84Vidarabine phosphate
CAS:Vidarabine phosphate is an adenosine monophosphate analog.Formula:C10H14N5O7PPurity:99.75%Color and Shape:White Crystalline PowderMolecular weight:347.22Ref: TM-T20048
5mg34.00€10mg44.00€1mL*10mM (DMSO)44.00€25mg84.00€50mg113.00€100mg170.00€200mg250.00€500mg427.00€HBV-IN-19
CAS:HBV-IN19 suppresses HBV, cutting HBsAg output, useful for chronic HBV study.Formula:C24H30N2O6Color and Shape:SolidMolecular weight:442.5Alamifovir
CAS:Alamifovir: HBV-specific antiviral, purine analog prodrug; active against wild-type/lamivudine-resistant HBV; inhibits DNA initiation/packaging.Formula:C19H20F6N5O5PSColor and Shape:SolidMolecular weight:575.42(-)-5′-Noraristeromycin
CAS:(-)-5′-Noraristeromycin is an antiviral agent.Formula:C10H13N5O3Color and Shape:SolidMolecular weight:251.24Bentysrepinine
CAS:Bentysrepinine, a novel anti-HBV agent, inhibits DNA-HBV and cccDNA activities for the treatment of hepatitis B virus (HBV)-infected hepatitis.Formula:C29H35N3O4Purity:98%Color and Shape:SolidMolecular weight:489.61NVP018
CAS:NVP018 (BC 556) inhibits HBV, HCV, HIV-1 replication, barely affects drug transporters, and resists HCV/HIV-1 resistance development.Formula:C45H62FN5O11Color and Shape:SolidMolecular weight:868Taribavirin hydrochloride
CAS:Taribavirin HCl: oral drug targeting HCV in liver, spares red blood cells, aims to reduce anemia risk.Formula:C8H14ClN5O4Purity:98%Color and Shape:SolidMolecular weight:279.68RIG-1 modulator 1
CAS:RIG-1 modulator 1 is useful for the treatment of viral infections including influenza virus, HBV, HCV and HIV.Formula:C14H17N5OS2Purity:98%Color and Shape:SolidMolecular weight:335.45Taribavirin
CAS:Taribavirin: oral drug targeting HCV in liver, spares RBCs to reduce risk of anemia.Formula:C8H13N5O4Purity:98%Color and Shape:SolidMolecular weight:243.22BA-53038B
CAS:BA-53038B is an HBV core protein allosteric modulator (CpAM), binding to the HAP pocket and modulating HBV capsid assembly in a distinct manner (EC50: 3.32 μM).Formula:C14H16ClNOColor and Shape:SolidMolecular weight:249.74DVR-01
CAS:DVR-01 is an HBV capsid inhibitor and can be used in studies about the treatment of Hepatitis B virus (HBV) infection and related conditions.
Formula:C20H23ClN2O3SPurity:99.95%Color and Shape:SolidMolecular weight:406.93L-Fd4A
CAS:L-Fd4A (compound 36) is an adenine derivative with anti-HIV (EC50=1.5μM) and anti-HBV (EC50=1.7μM) effects, low cytotoxicity.Formula:C10H10FN5O2Color and Shape:SolidMolecular weight:251.22Lagociclovir
CAS:Lagociclovir (MIV-210), a nucleoside analogue antiviral, treats HBV by inhibiting its replication in liver cancer cells.Formula:C10H12FN5O3Purity:99.18% - 99.74%Color and Shape:SolidMolecular weight:269.23YZ51
CAS:YZ51, a novel potent inhibitor of ribonucleotide reductase (RR), inhibits hepatitis B virus replication by targeting ribonucleotide reductase M2 protein.Formula:C16H14FNO2Color and Shape:SolidMolecular weight:271.29
